New Zealand markets open in 1 hour 15 minutes

  • NZX 50

    10,868.70
    -90.11 (-0.82%)
     

  • NZD/USD

    0.6246
    +0.0023 (+0.37%)
     

  • ALL ORDS

    6,746.50
    -131.40 (-1.91%)
     

  • OIL

    105.92
    -3.86 (-3.52%)
     

  • GOLD

    1,807.90
    -9.60 (-0.53%)
     

Global Contrast Media Injectors (Single Head, Dual Head) Market Analysis Report 2022-2030: Increasing Usage of Consumables for Several Diagnostic Procedures - ResearchAndMarkets.com

·3-min read

DUBLIN, May 24, 2022--(BUSINESS WIRE)--The "Contrast Media Injectors Market Size, Share & Trends Analysis Report by Product (Injector Systems, Consumables), by Type (Single Head, Dual Head), by Application, by End Use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global contrast media injectors market is expected to reach USD 1.65 billion by 2030, registering a CAGR of 4.83%

The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.

COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume.

However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.

Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.

Contrast Media Injectors Market Report Highlights

  • by product, injector systems accounted for the largest market share of 61.33% in 2021, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others.

  • by type, single head injectors accounted for the largest market share of 44.44% in 2021, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive.

  • Based on the application, the radiology segment dominated the market with around 47.39% of the revenue share in 2021, because it is the primary procedure used for the diagnosis of several chronic diseases.

  • Based on the end use, the hospitals segment dominated the market with around 68.07% of the revenue share in 2021, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes.

  • Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 5.41% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries.

Market Dynamics

Market Driver Analysis

  • Increasing demand for minimally invasive surgeries

  • Increasing application in neurosurgeries and orthopedic surgeries

  • Technological advancement in contrast media injectors

  • Growing Number Of Regulatory Approvals

Market Restraints Analysis

  • Prolonged Approval Process

  • High Cost Of Contrast Media Injectors

Contrast Media Injectors: Market Analysis Tools

  • Industry Analysis - Porter's Five Forces Analysis

  • SWOT Analysis, by PEST

Impact of COVID-19 on Market& Post Pandemic Insights

Competitive Analysis

Company Categorization

  • Innovators

  • Market Leaders

Vendor Landscape

  • Key Company Market Share Analysis, 2021

  • Major Deals and Strategic Alliances

  • New Product Launch

  • Expansion

  • Acquisition

  • Market Entry Strategies

Company Profiles

  • Bayer Healthcare LLC

  • Bracco Group

  • Ulrich Medical

  • Guerbet Group

  • Medtron AG

  • Nemoto Kyorindo Co. Ltd.

  • Hong Kong Medi Co Limited

For more information about this report visit https://www.researchandmarkets.com/r/x3lpxj

View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005779/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest stories

  • Ohio Bride's $3.75 Thrifted Wedding Dress Goes Viral on TikTok

    Jillian Lynch's $8 wedding shoes were also thrifted for her big day

  • Dogs Descended from Two Populations of Ancient Grey Wolves, Study Finds

    "The search continues to narrow down exactly where dogs come from," said Dr. Anders Bergström, an author of the study from the Francis Crick Institute

  • Stock Doomsayers Vindicated in Historic First Half: Markets Wrap

    (Bloomberg) -- The selloff in stocks deepened after weak consumer-spending data fueled worries about a recession, with the S&P 500 suffering its cruelest first half since Richard Nixon’s presidency.Most Read from BloombergDemocrats Weigh Paring Biden Tax Hike to Win Over ManchinThe Wheels Have Come Off Electric VehiclesSupreme Court Crimps Biden’s Climate Agenda With Limits on EPAStocks Jolted by Recession Scare as Bonds Surge: Markets WrapTrump’s Final Scene Didn’t Go According to ScriptIt was

  • Brompton Split Banc Corp. Establishes At-the-Market Equity Program

    Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- (TSX: SBC, SBC.PR.A) Brompton Split Banc Corp. (the “Company”) is pleased to announce it has established an at-the-market equity program (“ATM Program”) that allows the Company to issue class A and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) to the public from time to time, at the Company’s discretion. Any Class A Shares or Preferre

  • U.S. ports brace for July 1 dockworker contract expiration

    Yahoo Finance reporter Dani Romero outlines the likelihood of a dockworker strike between U.S. ports as negotiations continue ahead of their contract's July 1 expiration.

  • Sale of undelivered Iveco Group N.V. common shares

    Demerger of CNH Industrial N.V. through the Separation and Transfer of its “On-Highway” Business to Iveco Group N.V. – Final Settlement Sale of undelivered Iveco Group N.V. common shares London / Turin, 30th June 2022 CNH Industrial N.V. (CUSIP: N20944 109; ISIN: NL0010545661; TICKER: CNHI) and Iveco Group N.V. (ISIN: NL0015000LU4; TICKER: IVG) announce the final corporate activities related to the spin-off of CNH Industrial N.V.’s On-Highway business to Iveco Group N.V. (“the Demerger”), consum

  • Horizon Bancorp, Inc. Announces Earnings Conference Call to Review Second Quarter 2022 Results on July 28

    MICHIGAN CITY, Ind., June 30, 2022 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) — Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m. CT on Thursday, July 28, 2022 to review its second quarter 2022 financial results. The Company’s second quarter 2022 news release will be released after markets close on Wednesday, July 27, 2022. It will be available in the “Investor Relations” section of the Company’s website, www.horizonbank.com. Participants may access the live

  • Orion Engineered Carbons Declares Interim Quarterly Dividend

    HOUSTON, June 30, 2022--Orion Engineered Carbons S.A. (NYSE: OEC), a specialty chemical company, today announced that its board of directors has declared an interim dividend to be paid in the fourth quarter of 2022 of $0.0207 per common share of the company, which is equivalent to the aggregate amount of approximately $1.25 million based on the number of common shares currently outstanding.

  • Stranger Things: New trailer teases epic battle against Vecna in season finale

    ‘Your friends are not prepared for this fight’

  • California advances bid to create legal drug injection sites

    The California state Assembly on Thursday approved a controversial bill allowing Los Angeles, Oakland and San Francisco to set up places where opioid users could legally inject drugs in supervised settings. The move follows more than a year of legislative consideration, with proponents saying it would save lives and detractors saying it would enable drug addiction. The Assembly's approval sends the bill back to the state Senate for final consideration in August, after lawmakers return from a monthlong summer recess.

  • Stranger Things: When does season 4 part 2 release on Netflix?

    First part of the season arrived on Netflix on 27 May and the second part will arrive in July

  • Housing economist: ‘If you need a mortgage, get your rate locked in now’

    Nest Seekers International Chief Economist Erin Sykes talks the housing market, and why buyers should brace themselves for higher prices this year.

  • China’s COVID reopening ‘could exacerbate the inflation story’: Strategist

    Ryan Nauman, Market Strategist at Zephyr, and Global X ETFs Chief Investment Officer Jon Maier join Yahoo Finance Live to discuss the prospects of a market rebound amid the Fed's interest rate hike, tech stocks, and the continued shock to commodity prices from the Russia-Ukraine war.

  • Discover Financial Services Announces Second Quarter 2022 Earnings Release on July 20, 2022, and Conference Call on July 21, 2022

    RIVERWOODS, Ill., June 30, 2022--Discover Financial Services (NYSE: DFS) plans to report its second quarter 2022 results after the market closes on Wednesday, July 20, 2022. The earnings release will be available through Discover's Investor Relations website at https://investorrelations.discover.com.

  • New York Environmental Regulators Deny Greenidge’s Power Plant Permit

    The New York State Department of Environmental Conservation (NYSDEC) has denied bitcoin mining operation Greenidge Generation’s application to renew an air permit required to continue operating in New York.

  • JB Somers Is Living His Truth as a Gay Musician: 'It's Crazy the Weight That Comes Off of You'

    "It was in Nashville that I realized that this was not going away," Somers tells PEOPLE of accepting his sexuality, which he came to terms with in Music City

  • Granger Smith's Wife Amber Recalls Heartbreaking Moment She Told Her Kids Their Brother Had Died

    Granger and Amber Smith's 3-year-old son River Kelly died in a tragic drowning accident in June 2019

  • Archaea Announces Completion of Amendment and Upsize of Term Loan and Revolving Credit Facility

    HOUSTON, June 30, 2022--Archaea Energy Inc. ("Archaea," "the Company," or "we") (NYSE: LFG), an industry-leading renewable natural gas ("RNG") company, today announced that it1 has successfully closed the previously announced amendment to its Revolving Credit and Term Loan Agreement. Aggregate commitments now total $1.1 billion, an increase of approximately $630 million from the original facilities, including a $400 million senior secured term loan credit facility and a $700 million senior secur

  • Fortis Inc. to Hold Teleconference on July 28 to Discuss Second Quarter 2022 Results

    ST. JOHN'S, Newfoundland and Labrador, June 30, 2022 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its second quarter 2022 financial results on Thursday, July 28, 2022. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's second quarter financial results. Shareholders,

  • Granite Wins Recognition for Early Talent Engagement

    WATSONVILLE, Calif., June 30, 2022--On June 14th, Granite (NYSE:GVA), was announced as a winner of Handshake’s Early Talent Awards (ETA). This annual award program recognizes employers for best-in-class talent engagement and celebrates the top workplaces that attract Gen Z. This is Granite’s second ETA recognition in as many years.